BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/03/2009

FDA's CBER Invites Blood Establishments to Pilot eSubmitter Program for Source Plasma

The FDA's Center for Biologics Evaluation and Research is launching a pilot program to evaluate its eSubmitter system for submitting biologics license applications and supplements for blood and blood components, and is inviting blood establishments that collect Source Plasma to participate

Source: Federal Register — Food and Drug AdministrationOpen original release →